Cover image of the article: Pharmacological Evidences for the Antiamnesic Effects of Desmodium gangeticum in mice

Image Credit:Iran J Pharm Res

Pharmacological Evidences for the Antiamnesic Effects of Desmodium gangeticum in mice

Authors

Joshi Hanumanthachar1,*, Parle Milind1
1Division of Pharmacology, Department of Pharmaceutical Sciences,Guru Jambheshwar University of Science and Technology, Hisar, Haryana, India
*Corresponding Author: Division of Pharmacology, Department of Pharmaceutical Sciences,Guru Jambheshwar University of Science and Technology, Hisar, Haryana, India. Email:amanjoshi17@yahoo.com

Iranian Journal of Pharmaceutical Research:Vol. 6, issue 3; 199-207
Published online:Nov 20, 2010
Article type:Research Article
Received:Jun 21, 2006
Accepted:Dec 21, 2006
How to Cite:Hanumanthachar J, Milind P. Pharmacological Evidences for the Antiamnesic Effects of Desmodium gangeticum in mice. Iran J Pharm Res. 2022;6(3):e128333. doi: https://doi.org/10.22037/ijpr.2010.722

Abstract

Dementia is one of the age related mental problems and a characteristic symptom of various neurodegenerative disorders including Alzheimer’s disease. Desmodium gangeticum DC. (Leguminosae) is widely used in Ayurveda for treating various neurological disorders. In the present study, the effectiveness of aqueous extract of D. gangeticum in attenuating scopolamine-induced amnesia in mice was investigated. Passive avoidance paradigm was used to assess long-term memory. In order to delineate the possible mechanism through which D. gangeticum elicits the anti-amnesic effects, we studied its influence on central cholinergic activity by estimating the acetylcholine content of the whole brain and acetylcholinesterase activity at different regions of the mouse brain, viz., cerebral cortex, midbrain, medulla oblongata and cerebellum. Pretreatment with D. gangeticum (100 mg/kg and 200 mg/kg, p.o.) for seven successive days, reversed scopolamine induced amnesia in mice. D. gangeticum increased mice brain acetylcholine content and decreased acetyl cholinesterase activity in a similar manner to the standard cerebro-protective drug piracetam. Hence, aqueous extract of D. gangeticum can be used to delay the onset and reduce the severity of the symptoms of dementia and Alzheimer’s disease.

Highlights

Copyright

© 2022, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

14
Oct
2024
Anticholinesterase, Antioxidative and Neuroprotective Effects of Hydroethanolic Extracts of Guiera Senegalensis J. F. Gmel. Leaves on Scopolamine Induced Alzheimer’s Disease in Wistar Rat Models

Anticholinesterase, Antioxidative and Neuroprotective Effects of Hydroethanolic Extracts of Guiera Senegalensis J. F. Gmel. Leaves on Scopolamine Induced Alzheimer’s Disease in Wistar Rat Models

Foyet Harquin Simplice,
Jorelle Linda Damo Kamda,
Nyayi Simon Desire Guedang,
Alin Ciobica,
Fatima Zahra Kamal,
Guillaume Woumitna Camdi
,et al.

Harquin Simplice F, Linda Damo Kamda J, Simon Desire Guedang N, Ciobica A, Kamal FZ, et al. Anticholinesterase, Antioxidative and Neuroprotective Effects of Hydroethanolic Extracts of Guiera Senegalensis J. F. Gmel. Leaves on Scopolamine Induced Alzheimer’s Disease in Wistar Rat Models. Jundishapur J Nat Pharm Prod. 2024;19(4):e147530. doi: https://doi.org/10.5812/jjnpp-147530

2
Dec
2018
Ginkgo biloba Extract Decreases Scopolamine-Induced Congophilic Amyloid Plaques Accumulation in Male Rat's Brain

Ginkgo biloba Extract Decreases Scopolamine-Induced Congophilic Amyloid Plaques Accumulation in Male Rat's Brain

Emsehgol Nikmahzar,
Mehrdad Jahanshahi,
Fatemeh Babakordi

Nikmahzar E, Jahanshahi M, Babakordi F. Ginkgo biloba Extract Decreases Scopolamine-Induced Congophilic Amyloid Plaques Accumulation in Male Rat's Brain. Jundishapur J Nat Pharm Prod. 2018;13(4):e69143. doi: https://doi.org/10.5812/jjnpp.69143

31
May
2025
Neuroprotective Effects of Alhagi maurorum Extract in a Rat Model of Mild Cognitive Impairment

Neuroprotective Effects of Alhagi maurorum Extract in a Rat Model of Mild Cognitive Impairment

Omolbanin Karimi,
Ali Shamsizadeh,
Jalal Hassanshahi,
Zahra Taghipour,
Morteza Khademalhosseini,
Ayat Kaeedi
,et al.

Karimi O, Shamsizadeh A, Hassanshahi J, Taghipour Z, Khademalhosseini M, et al. Neuroprotective Effects of Alhagi maurorum Extract in a Rat Model of Mild Cognitive Impairment. Jundishapur J Nat Pharm Prod. 2025;20(3):e160528. doi: https://doi.org/10.5812/jjnpp-160528

28
Jul
2025
Investigating the Role of Gummosin in Improving Memory in the Scopolamine Damaged Memory Model for the Possible NMDA-CREB-Ca+2 Pathway

Investigating the Role of Gummosin in Improving Memory in the Scopolamine Damaged Memory Model for the Possible NMDA-CREB-Ca+2 Pathway

Atefeh Asadi-Rizi

Asadi-Rizi A. Investigating the Role of Gummosin in Improving Memory in the Scopolamine Damaged Memory Model for the Possible NMDA-CREB-Ca+2 Pathway. Zahedan J Res Med Sci. 2025;27(4):e164365. doi: https://doi.org/10.5812/zjrms-164365

26
Oct
2021
Effects of Aminoguanidine on Apoptosis in the Hippocampus and Memory Disorder in a Rat Model of Alzheimer’s Disease

Effects of Aminoguanidine on Apoptosis in the Hippocampus and Memory Disorder in a Rat Model of Alzheimer’s Disease

Hamid Reza Sameni,
Abbas Ali Vafaei,
Sam Zarbakhsh,
Afsaneh Talebian,
Mohammad Reza Aldaghi

Sameni HR, Vafaei AA, Zarbakhsh S, Talebian A, Aldaghi MR. Effects of Aminoguanidine on Apoptosis in the Hippocampus and Memory Disorder in a Rat Model of Alzheimer’s Disease. Middle East J Rehabil Health Stud. 2021;8(4):e115127. doi: https://doi.org/10.5812/mejrh.115127

More by these authors

Joshi HanumanthacharPubMedScholar
Parle MilindPubMedScholar
Share
Cited by
Metrics